PATHOPHYSIOLOGICAL ANALYSIS OF GOODPASTURE SYNDROME USING FcRγ-DEFICIENT MICE
PATHOPHYSIOLOGICAL ANALYSIS OF GOODPASTURE SYNDROME USING FcRγ-DEFICIENT MICE
批准号:
10670538
负责人:
HASEGAWA Yoshinori
金额:
$1.79万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Several recent studies have demonstrated the central role of Fe receptor (FcR) rather than the complement system in triggering hypersensitivity reactions including Goodpasture syndrome. We investigated the role of FcR for IgG (FcγR) using a murine model of accelerated anti-glomerular basement membrane (GBM) antibody-mediated glomerulonephritis and alveolitis as a representative of type II hypersensitivity diseases. Intravenous injection of rabbit anti-GBM antibody after preimmunization with normal rabbit IgG induced proteinuria and azotemia in wild-type C57BL/6 and CD40 +/- mice but not in FeR γ chain (FcRγ) -/- mice, or CD40 -/- mice. Light microscope findings revealed marked tissue damage in the glomeruli of wild-type C57BL/6 and CD40 +/- mice. However, no tissue damage except polymorphonuclear cell infiltration was observed in the glomeruli of FcRγ -/- mice. The glomeruli of CD40 -/- mice were almost normal. Immunohistochemistry revealed the binding of rabbit IgG to the GBM in all mice injected with anti-GBM antibody. However, depositions of mouse IgG and complement to the glomeruli were not observed in CD40 -/- mice, and deposition of fibrin was not observed in FcRγ -/-or CD40 -/- mice. Furthermore, anti-basement membrane antibody-mediated alveolitis was not induced in FcRγ -/- mice. These findings suggest that FcγR may initiate anti-basement membrane antibody-mediated renal and pulmonary disease, that is named as Goodpasture syndrome. We conclude that FcγR rather than the complement system is critically involved in the development of type II hypersensitivity diseases.
期刊论文(21)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Imaizumi K: "Bystander tumoricidal effect and gapjunctional communication in lung cancer cell lines." American Journal of Respiratory Cell and Mollecular Biology. 18. 205-212 (1998)
Imaizumi K:“肺癌细胞系中的旁观者肿瘤杀伤作用和间隙连接通讯。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Wakayama H: "Abolitionof Anti-Glomerular Basement Membrane Antibody-Mediated Nephritis in FcRg-Deficient Mice"European Journal of Immunology. (in press). (2000)
Wakayama H:“FcRg 缺陷小鼠中抗肾小球基底膜抗体介导的肾炎的消除”欧洲免疫学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Wakayama H: "IgG-mediated anaphylaxis via Fcγ receptor in CD40-deficient mice"Clinical and Experimental Immunology. 114. 154-160 (1998)
Wakayama H:“CD40 缺陷型小鼠中通过 Fcγ 受体介导的 IgG 过敏反应”《临床和实验免疫学》114. 154-160 (1998)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hasegawa Y: "Avoidance of bone marrow suppression using A-5021 as a Nucleoside analog for retrovirus-mediated herpes simplex virus type I thymidine kinase gene therapy"Cancer Gene Therapy. (in press). (2000)
长谷川 Y:“使用 A-5021 作为逆转录病毒介导的单纯疱疹病毒 I 型胸苷激酶基因治疗的核苷类似物来避免骨髓抑制”癌症基因治疗。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hasegawa Y, et al.: "Adoidance of bone marrow suppression using A-5021 as a nucleoside analog for retrovirus-mediated herpes simplex virus type I thymidine kinase gene therapy"Cancer Gene Therapy. (in press).
Hasekawa Y 等人:“使用 A-5021 作为逆转录病毒介导的单纯疱疹病毒 I 型胸苷激酶基因治疗的核苷类似物抑制骨髓抑制”癌症基因治疗。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 18 条
Establishment of a method for safe iPS cell production and acquisition of fully differentiated cells using a human artificial chromosome
-
批准号:25640108
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.58万
-
财政年份:2013
-
负责人:HASEGAWA Yoshinori
-
依托单位:
QOL in Friendless Elderly People
-
批准号:23653148
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$1.66万
-
财政年份:2011
-
负责人:HASEGAWA Yoshinori
-
依托单位:
Molecular Target of Regenerative Pulmonary Medicine for Chronic Obstructive Pulmonary Disease
-
批准号:23659431
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2011
-
负责人:HASEGAWA Yoshinori
-
依托单位:
Analysis of cancer metastasis using circulating tumor cells purified by micro-fluidics techniques
-
批准号:21390257
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.48万
-
财政年份:2009
-
负责人:HASEGAWA Yoshinori
-
依托单位:
THE ROLE OF GENETIC POLYMORPHISMS OF DRUG TRANSPORTER GENES FOR THE TREATMENT OF LUNG CANCER
-
批准号:17590786
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2005
-
负责人:HASEGAWA Yoshinori
-
依托单位:
PATHOPHYSIOLOGICAL ANALYSIS OF BRONCHIOLITIS OBLITERANCE USING CD40-DEFICIENT MICE AND GFP-TRANSGENIC MICE
-
批准号:15590804
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2003
-
负责人:HASEGAWA Yoshinori
-
依托单位:
PATHOPHYSIOLOGICAL ANALYSIS OF BRONCHIOLITIS OBLITERANCE USING CD40-DEFICIENT MICE
-
批准号:13670596
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2001
-
负责人:HASEGAWA Yoshinori
-
依托单位:
ANALYSIS OF MACROPHAGE SPECIFICalpha1-ANTITRYPSIN PROMOTER IN PATIENTS WITH EMPHYSEMA
-
批准号:07670664
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.54万
-
财政年份:1995
-
负责人:HASEGAWA Yoshinori
-
依托单位:
海外基金